IMPLICATIONS OF FINDINGS IN THE CORONARY DRUG PROJECT FOR SECONDARY PREVENTION TRIALS IN CORONARY HEART-DISEASE

被引：17

作者：

CANNER, PL

机构：

来源：

关键词：

D O I：

10.1161/01.CIR.63.6.1342

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1342 / 1350

页数：9

共 33 条

[1] [Anonymous], 1971, Br Med J, V4, P767
[2] [Anonymous], 1972, JAMA, V220, P996
[3] [Anonymous], 1975, JAMA, V231, P360
[4] BUCHWALD H, 1974, CIRCULATION S1, V49, P1
[5] CORNFIELD J, 1962, FED PROC, V21, P58
[6] SECONDARY PREVENTION TRIALS USING CLOFIBRATE - JOINT COMMENTARY ON NEWCASTLE AND SCOTTISH TRIALS
DEWAR, HA
OLIVER, MF
[J]. BRITISH MEDICAL JOURNAL, 1971, 4 (5790) : 784 - &
[7] MORTALITY IN RELATION TO SMOKING - 20 YEARS OBSERVATIONS ON MALE BRITISH DOCTORS
DOLL, R
PETO, R
[J]. BRITISH MEDICAL JOURNAL, 1976, 2 (6051) : 1525 - 1536
[8] FLEISS JL, 1973, STATISTICAL METHODS
[9] SAMPLE SIZES FOR MEDICAL TRIALS WITH SPECIAL REFERENCE TO LONG-TERM THERAPY
HALPERIN, M
ROGOT, E
GURIAN, J
EDERER, F
[J]. JOURNAL OF CHRONIC DISEASES, 1968, 21 (01): : 13 - &
[10] LEREN P, 1966, ACTA MED SCAND S466, P1